查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1627953

羊膜穿刺針市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Amniocentesis Needle Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球羊膜穿刺針市值為 1.767 億美元，預計 2024 年至 2032 年複合年成長率為 4.9%。自體免疫疾病，這會使懷孕變得複雜並增加胎兒健康問題的風險。這些疾病以及越來越多的先天性疾病，導致對羊膜穿刺術的需求不斷成長，羊膜穿刺術可以提供重要的早期診斷並改善胎兒健康的管理。

羊膜穿刺針設計和功能的技術進步有助於提高這些手術的安全性和效率。現代針具有諸如用於精確控制深度的可調式塞子和用於基於注射器的液體提取的安全連接器等功能。這些創新有助於降低胎兒和周圍組織的風險，從而促進更安全的手術並增強醫療保健提供者的信心。針頭設計的改進進一步推動了羊膜穿刺術作為可靠診斷工具的採用。

羊膜穿刺針市場依針長度分為三個部分：100至150毫米、小於100毫米和大於150毫米。 2023 年，100 至 150 毫米細分市場佔據市場主導地位，營收達 9,220 萬美元。此範圍內的針非常適合進入羊膜囊，尤其是在懷孕中期，此時羊膜囊位於腹部表面下方約 8 至 12 公分處。這些針提供了提取足夠羊水的最佳深度，確保準確的測試並最大限度地降低手術風險。它們的精確性和安全性使其成為臨床醫生進行羊膜穿刺術的首選。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 1.767 億美元
預測值 2.726 億美元
複合年成長率 4.9%

依手術方式，羊膜穿刺針市場包括羊膜穿刺術、羊膜減縮術、胎兒輸血、羊膜腔輸注術和臍帶穿刺術。羊膜穿刺術佔據了最大的市場佔有率，到2023 年佔總數的33.1%。查測試無法總是證實這些疾病。

由於先天性疾病發病率較高和醫療基礎設施先進，2023 年美國羊膜穿刺針市場價值為 6,260 萬美元，繼續保持領先地位。由於重視早期診斷和專門的產前護理，預計美國對羊膜穿刺術的需求將保持強勁，進一步推動市場成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 羊膜穿刺術數量不斷增加
      • 先天性疾病負擔日益加重
      • 準媽媽慢性病盛行率上升
      • 羊膜穿刺針的技術進步
    • 產業陷阱與挑戰
      • 替代方法的可用性
      • 缺乏熟練的專業人員
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望

第 5 章：市場估計與預測：按產品類型，2021 - 2032

  • 主要趨勢
  • 100 至 150 毫米
  • 小於100毫米
  • 大於150毫米

第 6 章：市場估計與預測：按程序，2021 - 2032

  • 主要趨勢
  • 羊膜穿刺程序
  • 羊膜縮小手術
  • 胎兒輸血
  • 羊膜腔灌注程序
  • 臍帶穿刺程序

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 診斷中心
  • 診所
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 9 章：公司簡介

  • Becton, Dickinson and Company
  • Biopsybell
  • Cardinal Health
  • Eurosurgical
  • Laboratoire CCD
  • MDL
  • McKesson Corporation
  • Medax
  • Medline Industries
  • Moller Medical
  • RI.MOS
  • Roko
  • Suzhou Leapmed Healthcare Corporation
  • The Cooper Companies
  • Vigeo
簡介目錄
Product Code: 8186

The Global Amniocentesis Needle Market was valued at USD 176.7 million in 2023 and is projected to grow at 4.9% CAGR from 2024 to 2032. A key factor driving this market is the rising prevalence of chronic conditions in pregnant women, such as diabetes, hypertension, and autoimmune disorders, which can complicate pregnancies and increase the risk of fetal health issues. These conditions, alongside a growing number of congenital disorders, are contributing to the rising demand for amniocentesis procedures, which offer critical early diagnosis and improved management of fetal health.

Technological advancements in the design and functionality of amniocentesis needles help enhance the safety and efficiency of these procedures. Modern needles have features like adjustable stoppers for precise depth control and secure connectors for syringe-based fluid extraction. These innovations help reduce risks to the fetus and surrounding tissues, thus promoting safer procedures and increasing confidence among healthcare providers. The improvements in needle design are further boosting the adoption of amniocentesis as a reliable diagnostic tool.

The amniocentesis needle market is categorized by needle length into three segments: 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The 100 to 150 mm segment dominated the market in 2023, generating USD 92.2 million in revenue. Needles in this range are ideal for accessing the amniotic sac, especially during the second trimester when the sac is positioned approximately 8 to 12 cm below the abdominal surface. These needles offer optimal depth for extracting sufficient amniotic fluid, ensuring accurate testing and minimizing procedural risks. Their precision and safety features make them a preferred choice for clinicians performing amniocentesis.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$176.7 Million
Forecast Value$272.6 Million
CAGR4.9%

By procedure, the amniocentesis needle market includes amniocentesis, amnioreduction, fetal blood transfusions, amnioinfusion, and cordocentesis. Amniocentesis procedures represented the largest market share, accounting for 33.1% of the total in 2023. Known for its high accuracy, amniocentesis is particularly effective in providing conclusive diagnoses, such as detecting genetic conditions like Down syndrome, which screening tests cannot always confirm.

The U.S. amniocentesis needle market, valued at USD 62.6 million in 2023, continues to lead due to a higher incidence of congenital disorders and an advanced healthcare infrastructure. With an emphasis on early diagnosis and specialized prenatal care, the demand for amniocentesis is expected to remain strong in the U.S., further driving market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of amniocentesis procedures
      • 3.2.1.2 Growing burden of congenital disorders
      • 3.2.1.3 Rising prevalence of chronic diseases among expectant mothers
      • 3.2.1.4 Technological advancements in amniocentesis needles
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternative methods
      • 3.2.2.2 Dearth of skilled professionals
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 100 to 150 mm
  • 5.3 Smaller than 100 mm
  • 5.4 Larger than 150 mm

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Amniocentesis procedures
  • 6.3 Amnioreduction procedures
  • 6.4 Fetal blood transfusions
  • 6.5 Amnioinfusion procedures
  • 6.6 Cordocentesis procedures

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic centers
  • 7.4 Clinics
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Becton, Dickinson and Company
  • 9.2 Biopsybell
  • 9.3 Cardinal Health
  • 9.4 Eurosurgical
  • 9.5 Laboratoire CCD
  • 9.6 M.D.L
  • 9.7 McKesson Corporation
  • 9.8 Medax
  • 9.9 Medline Industries
  • 9.10 Moller Medical
  • 9.11 RI.MOS
  • 9.12 Roko
  • 9.13 Suzhou Leapmed Healthcare Corporation
  • 9.14 The Cooper Companies
  • 9.15 Vigeo